UBS’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$144K Sell
6,021
-43,336
-88% -$1.1M ﹤0.01% 5543
2014
Q2
$1.23M Buy
49,357
+48,217
+4,230% +$1.06M ﹤0.01% 3356
2014
Q1
$24K Buy
1,140
+307
+37% +$6.68K ﹤0.01% 7864
2013
Q4
$19K Buy
+833
New +$16.9K ﹤0.01% 8229
2013
Q3
Sell
-20,155
Closed -$418K 10824
2013
Q2
$418K Buy
+20,155
New +$451K ﹤0.01% 4272

Other funds holding CONE

UBS's CONE Position: Q3 2014 in Review

UBS reduced its CyrusOne Inc Common Stock (CONE) stake by 88% in Q3 2014, selling an estimated $1.1M and leaving 6,021 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #5543.

UBS first reported a position in CONE in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.23M in Q2 2014. 141 funds tracked by Wall St. Rank hold CONE as of Q3 2014.

  • UBS held 6,021 shares of CyrusOne Inc Common Stock worth $144K as of Q3 2014.
  • UBS sold 43,336 CyrusOne Inc Common Stock shares in Q3 2014, an estimated $1.1M.
  • CyrusOne Inc Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5543 holding.
  • UBS first reported a position in CyrusOne Inc Common Stock in Q2 2013 and has held it in 5 quarters since.
  • UBS's CyrusOne Inc Common Stock position peaked at $1.23M in Q2 2014.
  • 141 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.